JPMorgan Chase & Co. Boosts Intuitive Surgical (NASDAQ:ISRG) Price Target to $675.00

Intuitive Surgical (NASDAQ:ISRG) had its price objective lifted by equities researchers at JPMorgan Chase & Co. from $575.00 to $675.00 in a report issued on Friday,Benzinga reports. The brokerage currently has an “overweight” rating on the medical equipment provider’s stock. JPMorgan Chase & Co.‘s price objective suggests a potential upside of 15.57% from the company’s previous close.

Other analysts have also recently issued research reports about the company. Raymond James lifted their price target on Intuitive Surgical from $500.00 to $540.00 and gave the stock an “outperform” rating in a research report on Monday, October 14th. Truist Financial lifted their target price on Intuitive Surgical from $570.00 to $640.00 and gave the stock a “buy” rating in a report on Wednesday, December 18th. The Goldman Sachs Group set a $604.00 price target on shares of Intuitive Surgical in a report on Friday, October 18th. Royal Bank of Canada lifted their price objective on shares of Intuitive Surgical from $525.00 to $555.00 and gave the company an “outperform” rating in a research note on Friday, October 18th. Finally, Citigroup increased their price objective on shares of Intuitive Surgical from $567.00 to $640.00 and gave the stock a “buy” rating in a research note on Wednesday, December 11th. One research analyst has rated the stock with a sell rating, three have given a hold rating and fifteen have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $583.83.

Intuitive Surgical Trading Down 4.0 %

Shares of ISRG opened at $584.05 on Friday. The firm has a market cap of $208.03 billion, a PE ratio of 93.90, a P/E/G ratio of 5.19 and a beta of 1.39. Intuitive Surgical has a 12 month low of $364.17 and a 12 month high of $616.00. The stock has a fifty day moving average price of $547.16 and a 200-day moving average price of $504.35.

Insider Activity at Intuitive Surgical

In other Intuitive Surgical news, insider Jamie Samath sold 269 shares of Intuitive Surgical stock in a transaction dated Monday, November 11th. The shares were sold at an average price of $539.89, for a total transaction of $145,230.41. Following the completion of the sale, the insider now directly owns 8,757 shares in the company, valued at $4,727,816.73. This trade represents a 2.98 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Robert Desantis sold 376 shares of the stock in a transaction that occurred on Friday, November 29th. The stock was sold at an average price of $539.00, for a total transaction of $202,664.00. Following the transaction, the executive vice president now directly owns 5,506 shares of the company’s stock, valued at $2,967,734. The trade was a 6.39 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 42,475 shares of company stock worth $22,070,807. Insiders own 0.90% of the company’s stock.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently made changes to their positions in the business. Patron Partners LLC boosted its holdings in Intuitive Surgical by 3.7% in the fourth quarter. Patron Partners LLC now owns 1,890 shares of the medical equipment provider’s stock valued at $987,000 after purchasing an additional 67 shares during the period. Trust Point Inc. raised its position in Intuitive Surgical by 7.7% in the 4th quarter. Trust Point Inc. now owns 2,262 shares of the medical equipment provider’s stock valued at $1,181,000 after purchasing an additional 162 shares in the last quarter. Alliance Wealth Advisors LLC UT purchased a new position in shares of Intuitive Surgical in the 4th quarter valued at about $278,000. Optas LLC grew its position in shares of Intuitive Surgical by 22.1% during the fourth quarter. Optas LLC now owns 795 shares of the medical equipment provider’s stock worth $415,000 after buying an additional 144 shares in the last quarter. Finally, Financial Life Planners purchased a new stake in shares of Intuitive Surgical during the fourth quarter worth approximately $81,000. Hedge funds and other institutional investors own 83.64% of the company’s stock.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.